Skip to main content
AmigoFish

CEimpact Podcast

CEimpactAudio

Format:
Podcast
New episodes:
Several times a week
Typical length:
about 45 minutes
Latest episode:
Not rated yet

About this show

The CEimpact Podcast features two shows:

GameChangers Clinical Updates

Precept2Practice

GameChangers Clinical Update: Hosted by Rachel Maynard, PharmD, GameChangers helps pharmacists and pharmacy technicians stay current with the developments shaping patient care. Each episode turns emerging evidence and practice updates into insights you can use with confidence.

New episodes arrive every Monday. CEimpact subscribers can listen or watch or use the downloadable Practice Resource to apply what they learn, and claim CE, all included with their CE subscription.

Explore episodes and CE opportunities at ceimpact.com/resources/podcast (https://www.ceimpact.com/resources/podcast/).

Precept2Practice Hosted by Kate Newman, PharmD, the Precept2Practice course gives preceptors practical tools to mentor students and residents with confidence.

New episodes arrive on the third Wednesday of each month. Preceptor By Design™ subscribers can earn CE credit and access the Practice Resource for each episode.

Follow the CEimpact Podcast and turn your commute, coffee break, or time between patients into an opportunity to stay current, strengthen your skills, and grow your impact.

Covers: pharmacy continuing education, clinical pharmacy, pharmacotherapy, drug therapy updates, preceptor training, antimicrobial stewardship, women's health, hypertension management

Show details and episodes come from the publisher's public feed at rss.buzzsprout.com. Last updated . Names, artwork and text belong to their publishers.

Recently on this show

Summary of recent episodes, drawn from the publisher's feed.

The CEimpact Podcast offers two shows for pharmacy professionals: GameChangers, which covers emerging evidence and practice updates for pharmacists and technicians, and Precept2Practice, which gives preceptors tools to mentor students and residents. Recent episodes cover race-free eGFR, hypertension beyond initial therapy, multivitamin evidence, and UTI management.

Report a problem with this summary

Cosmos

Similar by topic and creator

See the full Cosmos

Similar shows

See all Education shows

Explore more

Episodes

  • How AI is Reshaping Patient Care

    · 35 min

    Artificial intelligence (AI) is rapidly transforming the healthcare landscape—and pharmacy is no exception. This course explores emerging and potential uses of AI in pharmacy practice, including workflow automation, drug information access, and tools that support patient care and clinical decision-making. You will gain insight into practical considerations, limitations, and ethical responsibilities pharmacists must navigate as AI becomes more integrated into practice. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Timothy Aungst, PharmD Professor of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current and potential uses of AI that support pharmacist-led patient care services. 2. Describe considerations, limitations, and ethical concerns related to implementing AI tools in pharmacy practice. Rachel Maynard and Timothy Aungst have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-060-H04-P Initial release date: 3/23/2026 Expiration date: 3/23/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/How-AI-is-Reshaping-Patient-Care). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • Second-Generation Antipsychotics as Adjunctive Therapy for Depression

    · 34 min

    Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have an inadequate or partial response to antidepressants. This course reviews the clinical rationale for their use, highlights newly approved options, and examines key safety, efficacy, and monitoring considerations. You will gain practical guidance to support patient selection, counseling, and shared decision-making when these agents are incorporated into depression management. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Sarah Grady, PharmD, BCPS, BCPP Professor of Pharmacy Practice, Clinical Pharmacist Drake University/Broadlawns Medical Center GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of second-generation (atypical) antipsychotics as adjunctive therapy in the management of major depressive disorder. 2. Identify pharmacist-relevant considerations for counseling, monitoring, and risk benefit assessment when second-generation antipsychotics are used for depression. Rachel Maynard and Sarah Grady have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-059-H01-P Initial release date: 3/16/2026 Expiration date: 3/16/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/Second-Generation-Antipsychotics-as-Adjunctive-Therapy-for-Depression). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • Recent Updates on GLP-1 Therapies

    · 46 min

    GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight management and ongoing investigations into GLP‑1 therapies for conditions beyond diabetes and obesity. You will gain a timely overview of recent developments in GLP‑1s and how pharmacists can anticipate and support their evolving role in patient care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Christine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Professor, Pharmacy Practice and Clinical Pharmacist Midwestern University GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent regulatory and clinical updates related to GLP‑1 receptor agonists, including new formulations. 2. Describe emerging areas of research into the use of GLP‑1 therapies beyond diabetes and obesity treatment. Rachel Maynard has no relevant financial relationships with ineligible companies to disclose. Christie Schumacher is a speaker for and is on the advisory board for Abbott. All relevant financial relationships have been mitigated. 0.1 CEU/1.0 Hr UAN: 0107-0000-26-081-H01-P Initial release date: 3/9/2026 Expiration date: 3/9/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/Recent-Updates-on-GLP-1-Therapies). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • Shared Clinical Decision-Making and the Pharmacist's Role

    · 43 min

    Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course explains what shared clinical decision‑making means in the context of immunizations, examines how it affects pediatric vaccine discussions, and highlights opportunities for pharmacists to support informed, individualized conversations with patients and caregivers. You will gain clarity on how to apply shared clinical decision‑making principles—alongside proven health coaching strategies—to strengthen patient trust and foster more meaningful dialogue in pharmacy practice. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Elizabeth Skoy, PharmD, RPh Professor North Dakota State University GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe shared clinical decision-making and how it applies to recent pediatric vaccine recommendations. 2. Identify the pharmacist's roles in counseling, education, and facilitating shared clinical decision-making conversations with patients and caregivers. Rachel Maynard and Elizabeth Skoy have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-077-H01-P Initial release date: 3/2/2026 Expiration date: 3/2/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/TITLE). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • Balancing the Benefits and Risks of Gabapentin

    · 29 min

    As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety and scope of use are also rising. This episode explores recent trends in gabapentin use, highlights key patient safety concerns, and examines pharmacist-led opportunities to reduce risks through education and medication review. You will walk away with timely insights to help navigate the growing complexities and responsibilities associated with gabapentin use. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Nakia Duncan, PharmD BCGP, BCPS Associate Professor/ Pain& Palliative Care Clinical Pharmacist Texas Tech Health Science Center - School of Pharmacy GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent national prescribing trends and safety concerns associated with gabapentin use. 2. Identify pharmacist-led strategies to support safe use, patient education, and medication review involving gabapentin. Rachel Maynard and Nakia Duncan have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-053-H01-P Initial release date: 2/23/2026 Expiration date: 2/23/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/Balancing-the-Benefits-and-Risks-of-Gabapentin). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • Updates in HIV PEP Protocols and Guidelines

    · 41 min

    Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures — reflecting advances in antiretroviral therapy and evolving evidence. This course summarizes key changes, including preferred regimens, testing/follow‑up modifications, and special‑population considerations, and explores how these updates influence clinical practice. You will gain the practical knowledge needed to inform prompt PEP decision‑making, patient counseling, and care coordination. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Kenric Ware, Pharm D Clinical Associate Professor of Pharmacy Practice Mercer University GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current guideline recommendations for initiating HIV PEP after occupational and non-occupational exposure. 2. Describe key considerations for selecting and managing HIV PEP regimens. Rachel Maynard and Kenric Ware have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-052-H01-P Initial release date: 2/16/2026 Expiration date: 2/16/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/Updates-in-HIV-PEP-Protocols-and-Guidelines). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • Updates in HIV PrEP Therapy Options

    · 39 min

    Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance — are changing the landscape of Pre-Exposure Prophylaxis (PrEP) therapy. This course reviews the latest developments, compares prevention strategies, and examines how these changes affect PrEP delivery, counseling, and monitoring. You will gain timely insights to better counsel patients, support adherence, and contribute to prevention strategies in your practice. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST David Hachey, PharmD, AAHIVP Professor Idaho State University GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe key new HIV PrEP therapy options recently approved or recommended, including their dosing schedules and clinical indications. 2. Identify pharmacist responsibilities when counseling patients about PrEP, including initiation, adherence, monitoring, and risk-benefit discussions. Rachel Maynard and David Hachey have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-049-H01-P Initial release date: 2/9/2026 Expiration date: 2/9/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/updates-in-hiv-prep-therapy-options/). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • The Role of Biosimilars in Managing Inflammatory Disease

    · 42 min

    With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges pharmacists may face when integrating biosimilars into care plans. You will walk away better prepared to support prescribers, counsel patients, and contribute to cost-effective, evidence-informed therapy decisions. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Reemal Zaheer, PharmD, CSP Pharmacist Johns Hopkins Medicine GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of biosimilars in the treatment of inflammatory conditions. 2. Describe considerations for the pharmacist when evaluating or counseling on biosimilar therapies. Rachel Maynard and Reemal Zaheer have no relevant financial relationships with ineligible companies to disclose. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-045-H01-P Initial release date: 2/2/2026 Expiration date: 2/2/2029 Additional CPE details can be found here (https://www.ceimpact.com/courses/the-role-of-biosimilars-in-managing-inflammatory-disease/). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • FDA Removes Boxed Warnings on Menopausal Hormone Therapy

    · 41 min

    Menopausal hormone therapy has long carried a boxed warning (formerly a "black box warning") that may not accurately reflect the therapy's risk-benefit profile for all patients. This course discusses the FDA's recent removal of boxed warnings for select hormone therapy (HT) products, the rationale for this change, and how evolving guidance may impact patient care. You will explore strategies to support evidence-based counseling and individualized decision-making for patients considering HT. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Erin Raney, PharmD Professor Midwestern University College of Pharmacy GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the FDA's updated position on boxed warnings for menopausal hormone therapy. 2. Identify key considerations for pharmacists when counseling patients about the benefits and risks of hormone therapy. Rachel Maynard and Erin Raney have no relevant financial relationships with ineligible companies to disclose. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-044-H01-P Initial release date: 1/26/2026 Expiration date: 1/26/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/FDA-Removes-Boxed-Warnings-on-Menopausal-Hormone-Therapy). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/) Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet
  • Key Updates on the Return of Ranitidine

    · 31 min

    Ranitidine — once withdrawn from the market over safety concerns — was recently re‑approved by the FDA in a reformulated version, raising important questions for pharmacists and patients alike. This course outlines the FDA’s recent approval, reviews the reformulated product's changes (including manufacturing and labeling), and examines practical considerations for dispensing, counseling, and patient safety. You will gain clarity on when ranitidine may be appropriate for use (again) and how to guide patients confidently in its safe use. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST K. Ashley Garling-Nanez, PharmD Assistant Director of Program UT Center of Health Communications GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more! What the Subscription Includes: The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: · Compliance and licensure CE · GameChangers Clinical Updates · Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/) PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit: - If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####). - To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/) CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the major safety and regulatory issues that prompted ranitidine's withdrawal, and the changes made in the reformulated product approved in 2025. 2. Describe pharmacist‑relevant considerations for dispensing, patient counseling, and transition from alternative acid‑reducing therapies. Rachel Maynard and K. Ashley Garling-Nanez have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-043-H01-P Initial release date: 1/19/2026 Expiration date: 1/19/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/Key-Updates-on-the-Return-of-Ranitidine). Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

    Not rated yet